NIH Closes Doors on Bug-Fighting Grant Reviews
Published Date: 3/27/2025
Notice
Summary
The National Institute of Allergy and Infectious Diseases is holding a closed meeting from April 30 to May 2, 2025, to review special grant applications focused on microbial diagnostics and decontamination. This meeting affects researchers applying for these grants and helps decide who gets funding to fight infectious diseases. The discussions are private to protect sensitive information and personal privacy.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
Closed NIAID Grant Review for Microbial Tech
The National Institute of Allergy and Infectious Diseases will hold a closed meeting from April 30 to May 2, 2025 (9:30 a.m. to 6:00 p.m.) in Rockville, MD to review SBIR (R43/R44), STTR (R41/R42), and SB1 grant applications for microbial diagnostics, detection, and decontamination. If you are a researcher or a small business applying for these grants, this meeting will decide who gets funding.
Meeting Closed to Protect Trade Secrets
The meeting will be closed to the public under 5 U.S.C. 552b(c)(4) and 552b(c)(6) because grant applications and discussions could reveal confidential trade secrets, patentable material, or personal information. The closure is intended to protect applicants' private business and personal information during the grant review on April 30–May 2, 2025.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
2026-16440, NIH Owned Invention Available for License: Soluble Tissue Factor, a Novel Target, and Antibodies, for Diagnosis, Prevention and Treatment of Thrombosis and Related Conditions
Scientists at the National Cancer Institute (NCI) have discovered a novel therapeutic, diagnostic and prognostic target for thrombosis: Soluble Tissue Factor (sTF). NCI has generated first-in- class antibodies and platform selectively neutralizing pathological coagulation while preserving normal hemostasis. This platform technology can be used to prevent, diagnose and treat pathological thrombosis caused by a variety of clinical conditions-including cancer, sepsis, infectious diseases (e.g., COVID), autoimmune disorders, trauma, heart conditions and inflammatory conditions. It offers a much more sensitive and specific test of thrombosis than the current D-dimer test. It may be applicable to any clinical condition which induces necroptosis, pyroptosis and NETtosis, such as cancer, neurodegenerative disease, ischemia-reperfusion and acute injuries, traumatic injuries, bacterial and viral infections, cardiovascular conditions, and atherosclerosis, inflammatory, autoimmune conditions, and others.
2026-16071, Proposed Collection; 60-Day Comment Request: The Impact of Clinical Research Training and Medical Education at the Clinical Center on Physician Careers in Academia and Clinical Research (Clinical Center)
In compliance with the requirement of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the Clinical Center, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-15565, Proposed Collection; 60-Day Comment Request, Data Use Certification for the NIH Brain Development Cohorts (NBDC) Data Hub, (National Institute on Drug Abuse)
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. The purpose of this revision is to update instructions for the Research Data Use Statement and the Progress Report, and to add new instructions for attesting to National Institute of Standards & Technology (NIST) security compliance, and for a Project Close-out at the time of project completion. Burden levels remain unchanged.
2026-14966, Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering a new Ebola vaccine invention for companies to license and develop quickly. This vaccine targets the Bundibugyo virus and promises fast and lasting protection, helping stop outbreaks in Central Africa. Businesses interested in licensing should act soon to bring this life-saving tech to market and can contact NIH for details.
Previous / Next Documents
Previous: 2025-05245, National Heart, Lung, and Blood Institute; Notice of Meeting
The National Heart, Lung, and Blood Institute is holding a virtual public meeting on April 23, 2025, to talk about important program policies and issues. Anyone interested can watch online, join in with comments, or request special help if needed. This is a great chance for the public and organizations to share their thoughts and stay updated on heart, lung, and blood health research plans.
Next: 2025-05247, Proposed Extension of Information Collection Request Submitted for Public Comment; Comment Request on Burden Related to Form 1099-PATR
The IRS wants your thoughts on keeping Form 1099-PATR, which co-op members use to report taxable payments. This form helps the IRS track money from cooperatives, and they’re checking if it’s too much work for folks to fill out. If you’re involved with co-ops, now’s the time to speak up before the paperwork sticks around longer!